The medical team at Al-Mouwasat Hospital in Al-Khobar has successfully performed a series of surgeries to remove cancerous kidneys, under the guidance of Dr. Abdulrahman Abdulkarim Al-Muhrej, a Consultant in…
bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company dedicated to noninvasive tests for early-stage cancer detection, has announced a securities purchase agreement with institutional investors. This agreement includes the…
Tasso, Inc., a leader in patient-centric blood collection solutions, recently surveyed over 600 U.S. adults aged 18 and older to explore their experiences and preferences regarding blood testing. The survey,…
Caracal Products & Services and I2Pure have announced a collaboration to introduce new cutting-edge disinfection and antimicrobial products. Caracal, a certified Minority Business Enterprise and Tier 1 diversity spend supplier,…
Novocure (NASDAQ: NVCR) has announced that the U.S. Food and Drug Administration (FDA) has approved Optune Lua® for use alongside PD-1/PD-L1 inhibitors or docetaxel. This treatment is intended for adult…
Heidelberg Engineering, a leader in ophthalmic imaging and healthcare data solutions, has announced FDA clearance for the SPECTRALIS® Flex Module. This innovative multimodal platform is specifically designed for diagnostic imaging…
Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company, has announced that the U.S. Food and Drug Administration (FDA) has approved the enVista® Envy™ intraocular lens (IOL),…
VISIE Inc., formerly Advanced Scanners, has successfully showcased Continuous Anatomic Auto Tracking (CAAT) for robotic-assisted total knee arthroplasty (RA-TKA) at its headquarters in Austin, TX. Continuous Anatomic Auto Tracking (CAAT)…
NanoVibronix, Inc. (NASDAQ: NAOV), a medical device company known for its UroShield®, PainShield®, and WoundShield® Surface Acoustic Wave (SAW) portable ultrasonic therapeutic devices, has announced a non-binding term sheet for…
Amprion, a global leader in neurodegenerative disorder diagnostics, has announced the successful initial close of $6 million in its $15 million Series B financing round. The round was led by…
Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology firm focused on developing innovative small molecules for immune-mediated diseases, has announced that its Investigational New Drug (IND) application for zetomipzomib,…
Charles River Laboratories International, Inc. (NYSE: CRL) has announced that its neuroscience drug discovery team will present 18 scientific posters at Neuroscience 2024, the annual meeting of the Society for…